| Product Code: ETC095780 | Publication Date: Jun 2021 | Updated Date: Mar 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The United States saw a significant increase in erythromycin import shipments in 2024, with top exporting countries being India, Switzerland, Canada, Australia, and China. The market exhibited very high concentration levels, indicating a strong dominance by these key players. The compound annual growth rate (CAGR) from 2020 to 2024 was an impressive 14.74%, with a remarkable growth rate of 81.01% from 2023 to 2024. This data suggests a thriving market for erythromycin imports in the United States, driven by key suppliers from around the world.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Erythromycin Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Erythromycin Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Erythromycin Market - Industry Life Cycle |
3.4 United States (US) Erythromycin Market - Porter's Five Forces |
3.5 United States (US) Erythromycin Market Revenues & Volume Share, By Formulation, 2022 & 2032F |
3.6 United States (US) Erythromycin Market Revenues & Volume Share, By Therapeutic Indications, 2022 & 2032F |
3.7 United States (US) Erythromycin Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 United States (US) Erythromycin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in the United States |
4.2.2 Rising awareness about the efficacy of erythromycin in treating various infections |
4.2.3 Growth in the geriatric population leading to higher demand for antibiotics |
4.2.4 Technological advancements in drug delivery systems for erythromycin |
4.2.5 Expansion of healthcare infrastructure and facilities in the US |
4.3 Market Restraints |
4.3.1 Emergence of antibiotic resistance impacting the effectiveness of erythromycin |
4.3.2 Stringent regulatory requirements for antibiotic drugs in the US |
4.3.3 Side effects associated with erythromycin limiting its usage |
4.3.4 Competition from alternative antibiotics and newer drug classes |
4.3.5 Price fluctuations in raw materials impacting the cost of erythromycin production |
5 United States (US) Erythromycin Market Trends |
6 United States (US) Erythromycin Market, By Types |
6.1 United States (US) Erythromycin Market, By Formulation |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Erythromycin Market Revenues & Volume, By Formulation, 2022 - 2032F |
6.1.3 United States (US) Erythromycin Market Revenues & Volume, By Gel, 2022 - 2032F |
6.1.4 United States (US) Erythromycin Market Revenues & Volume, By Tablet, 2022 - 2032F |
6.1.5 United States (US) Erythromycin Market Revenues & Volume, By Topical Solution, 2022 - 2032F |
6.1.6 United States (US) Erythromycin Market Revenues & Volume, By Ointment, 2022 - 2032F |
6.1.7 United States (US) Erythromycin Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 United States (US) Erythromycin Market, By Therapeutic Indications |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Erythromycin Market Revenues & Volume, By Respiratory Tract Infections, 2022 - 2032F |
6.2.3 United States (US) Erythromycin Market Revenues & Volume, By Eye Infections, 2022 - 2032F |
6.2.4 United States (US) Erythromycin Market Revenues & Volume, By Ear Infections, 2022 - 2032F |
6.2.5 United States (US) Erythromycin Market Revenues & Volume, By Skin and Soft Tissue Infections, 2022 - 2032F |
6.2.6 United States (US) Erythromycin Market Revenues & Volume, By Gastro-intestinal Infections, 2022 - 2032F |
6.2.7 United States (US) Erythromycin Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 United States (US) Erythromycin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Erythromycin Market Revenues & Volume, By Hospital Pharmacies, 2022 - 2032F |
6.3.3 United States (US) Erythromycin Market Revenues & Volume, By Retail Pharmacies, 2022 - 2032F |
6.3.4 United States (US) Erythromycin Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
7 United States (US) Erythromycin Market Import-Export Trade Statistics |
7.1 United States (US) Erythromycin Market Export to Major Countries |
7.2 United States (US) Erythromycin Market Imports from Major Countries |
8 United States (US) Erythromycin Market Key Performance Indicators |
8.1 Prescription rates of erythromycin by healthcare providers |
8.2 Patient adherence to erythromycin treatment regimens |
8.3 Rate of antibiotic resistance development for erythromycin |
8.4 Number of clinical trials and research studies on erythromycin in the US |
8.5 Adoption rate of newer formulations or delivery methods of erythromycin |
9 United States (US) Erythromycin Market - Opportunity Assessment |
9.1 United States (US) Erythromycin Market Opportunity Assessment, By Formulation, 2022 & 2032F |
9.2 United States (US) Erythromycin Market Opportunity Assessment, By Therapeutic Indications, 2022 & 2032F |
9.3 United States (US) Erythromycin Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 United States (US) Erythromycin Market - Competitive Landscape |
10.1 United States (US) Erythromycin Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Erythromycin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here